Ratings upgrade for Mariner mortgage trust
Solid exposure to the Australian mortgage market has contributed to an upgrading of Mariner Mortgage Trust’s rating by InvestorWeb Research from ‘buy’ to ‘strong buy’ in its second review within the space of a few months.
According to the researcher, the fund offered investors “one of the better exposures in the sector”.
The trust, which is managed by Mariner Mortgage Management — a joint venture between Mariner Financial and Ashe Morgan Winthrop — invests in a portfolio of commercial mortgages, cash and short-term securities.
Administrative responsibilities are outsourced to providers including Australian Mortgage Administration and registry services to BNP Paribas.
The researcher praised the fund’s lending procedures, low risk and above industry average performance with nominal returns to retail investors of around 6 per cent annually after fees.
The fund predominately invests in first registered mortgages over residential property, with some exposure to industrial, commercial and retail currently to a maximum loan size of $1.8 million.
Preferred loan terms are up to three years, and mortgages must have a maximum loan to value ratio of 70 per cent and a capacity to service debt ratio greater than 1.25 times. The trust also only lends in state capital cities and major regional locations.
The trust is available on BT, Macquarie and NetWealth wraps and master trusts.
Recommended for you
As the year draws to a close, a new report has explored the key trends and areas of focus for financial advisers over the last 12 months.
Assured Support explores five tips to help financial advisers embed compliance into the heart of their business, with 2025 set to see further regulatory change.
David Sipina has been sentenced to three years under an intensive correction order for his role in the unlicensed Courtenay House financial services.
As AFSLs endeavour to meet their breach reporting obligations, a legal expert has emphasised why robust documentation will prove fruitful, particularly in the face of potential regulatory investigations.
